ArticleBMC cancer2015

Patterns of resource utilization and cost for postmenopausal women with hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer in Europe.

Guy Jerusalem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.